7th September 2018

 

Deepbridge has recently deployed an investment of £250,000 into Levitex Foams Limited, through the Deepbridge Life Sciences EIS fund. This follows on from an initial seed funding investment of £150,000, via the Deepbridge Life Sciences SEIS fund. 

About Levitex Foams Ltd

Levitex Foams Ltd has developed a new foam product that aims to redistribute pressure and posture, with a particular focus on users that are bed-bound. Being bed-bound can potentially lead to pressure sores resulting in a worsening of the patient’s general health condition, which could lead to an extended and more costly stay in hospital.